Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | August 12, 2020 |
| Target | ImmunoScape |
| Sector | Life Science |
| Investor(s) | Anzu Partners |
| Deal Type | Venture |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 1.0B USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Anzu Partners is a venture capital and private equity firm that looks to develop and commercialize technological advancements in manufacturing, materials, monitoring/measurement, and modeling. This includes 3D printing, robotics, nanotechnology, composites, sensors, AI, and analytics. Anzu Partners was formed in 2014 and is headquartered in Boston, Massachusetts.
| Deal Context for Investor | # |
|---|---|
| Overall | 20 of 36 |
| Sector: Life Science | 8 of 11 |
| Type: Venture | 20 of 32 |
| Country: Singapore | 1 of 1 |
| Year: 2020 | 6 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-01 |
InterVenn Biosciences
South San Francisco, California, United States InterVenn Biosciences utilizes a proprietary glycoproteomic biomarker interrogation platform using AI and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression. InterVenn Biosciences was founded in 2017 and is based in South San Francisco, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-01 |
Azumo
Chicago, Illinois, United States Azumo is a provider of lighting solutions without glare on the screen. Azumo was founded in 2008 and is based in Chicago, Illinois. |
Buy | - |
